PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3375138-1	1988	The present study analyzed the effect of vasoactive intestinal peptide (VIP) on the content of dopamine (DA) and its main metabolite, DOPAC, in the rat brain.	3,4-Dihydroxyphenylacetic Acid	134-139	vasoactive intestinal peptide	Rattus norvegicus	41-70	
3375138-1	1988	The present study analyzed the effect of vasoactive intestinal peptide (VIP) on the content of dopamine (DA) and its main metabolite, DOPAC, in the rat brain.	3,4-Dihydroxyphenylacetic Acid	134-139	vasoactive intestinal peptide	Rattus norvegicus	72-75	
3375138-2	1988	Intracerebroventricular administration of VIP increased the DA and DOPAC content, causing a dose-dependent increase in the DOPAC/DA ratio in various regions of the brain.	3,4-Dihydroxyphenylacetic Acid	67-72	vasoactive intestinal peptide	Rattus norvegicus	42-45	
3375138-2	1988	Intracerebroventricular administration of VIP increased the DA and DOPAC content, causing a dose-dependent increase in the DOPAC/DA ratio in various regions of the brain.	3,4-Dihydroxyphenylacetic Acid	123-128	vasoactive intestinal peptide	Rattus norvegicus	42-45	
33220286-4	2021	KEY FINDINGS: In the cyclic animal in estrus, the treatment with Ant-VIP in the left ovarian bursa resulted in a reduction in testosterone serum levels and in ovarian levels of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC), without changes in 4-hydroxy-3-methoxyphenyl (MHPG) and norepinephrine (NE).	3,4-Dihydroxyphenylacetic Acid	190-220	vasoactive intestinal peptide	Rattus norvegicus	69-72	
33220286-4	2021	KEY FINDINGS: In the cyclic animal in estrus, the treatment with Ant-VIP in the left ovarian bursa resulted in a reduction in testosterone serum levels and in ovarian levels of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC), without changes in 4-hydroxy-3-methoxyphenyl (MHPG) and norepinephrine (NE).	3,4-Dihydroxyphenylacetic Acid	222-227	vasoactive intestinal peptide	Rattus norvegicus	69-72	
8875438-10	1996	administration of VIP (1 microgram/3 microliter) significantly increased median eminence DOPAC/DA ratio at 30 min, and serum PRL level at 15 min.	3,4-Dihydroxyphenylacetic Acid	89-94	vasoactive intestinal peptide	Rattus norvegicus	18-21